387 related articles for article (PubMed ID: 36111032)
1. Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.
Li A; Zhang M; Yang Y; Zhang J; Xie X; Li X; Zhang H
Ann Transl Med; 2022 Aug; 10(16):906. PubMed ID: 36111032
[TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF
Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290
[TBL] [Abstract][Full Text] [Related]
3. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
5. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
[TBL] [Abstract][Full Text] [Related]
6. Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Simpson EL; Prajapati VH; Leshem YA; Chovatiya R; de Bruin-Weller MS; Ständer S; Pink AE; Calimlim BM; Lee WJ; Teixeira H; Ladizinski B; Hu X; Yang Y; Liu Y; Liu M; Grada A; Platt AM; Silverberg JI
Dermatol Ther (Heidelb); 2024 May; 14(5):1127-1144. PubMed ID: 38696027
[TBL] [Abstract][Full Text] [Related]
7. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
[TBL] [Abstract][Full Text] [Related]
8. Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA; Chalmers JR; Apfelbacher C; Katoh N; Gerbens LAA; Schmitt J; Spuls PI; Thomas KS; Howells L; Williams HC; Simpson EL;
JAMA Dermatol; 2022 Dec; 158(12):1429-1435. PubMed ID: 36223090
[TBL] [Abstract][Full Text] [Related]
9. Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitis.
Lei DK; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Sacotte R; Patel KR; Singam V; Immaneni S; Kantor R; Hsu DY; Silverberg JI
Br J Dermatol; 2020 Nov; 183(5):875-882. PubMed ID: 32017011
[TBL] [Abstract][Full Text] [Related]
10. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
Silverberg JI; Chiesa Fuxench ZC; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY
Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
[TBL] [Abstract][Full Text] [Related]
11. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
Schwartzman G; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
Clin Exp Dermatol; 2022 Feb; 47(2):359-372. PubMed ID: 34623642
[TBL] [Abstract][Full Text] [Related]
13. Measurement Properties of 4 Patient-Reported Outcome Measures to Assess Sleep Disturbance in Adults With Atopic Dermatitis.
Lei DK; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Sacotte R; Patel KR; Singam V; Kantor R; Hsu DY; Cella D; Silverberg JI
Dermatitis; 2020; 31(5):321-327. PubMed ID: 32947460
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
[No Abstract] [Full Text] [Related]
15. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.
Fishbein AB; Lor J; Penedo FJ; Forrest CB; Griffith JW; Paller AS
J Am Acad Dermatol; 2023 Feb; 88(2):348-356. PubMed ID: 32504726
[TBL] [Abstract][Full Text] [Related]
17. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
Br J Dermatol; 2020 Nov; 183(5):e149-e170. PubMed ID: 33135789
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associations of fatigue in childhood atopic dermatitis: A cross-sectional study.
Rangel SM; Kim T; Sheth A; Blumstein A; Lai JS; Cella D; Paller AS; Silverberg JI
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):763-771. PubMed ID: 36541250
[TBL] [Abstract][Full Text] [Related]
19. Severity of disease and the quality of life indexes in infants with atopic dermatitis.
Köse SŞ; Akelma Z; Özmen S
Allergol Immunopathol (Madr); 2022; 50(3):55-61. PubMed ID: 35527656
[TBL] [Abstract][Full Text] [Related]
20. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.
Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Sacotte R; Patel KR; Singam V; Immaneni S; Kantor R; Hsu DY; Silverberg JI
Ann Allergy Asthma Immunol; 2020 Mar; 124(3):261-266. PubMed ID: 31830585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
